ANALYSIS THE CURRENT SISTUATION OF USE AT NGHE AN FRIENDSHIP GENERAL HOSPITAL

Đức Phúc Nguyễn, Hữu Việt Anh Nguyễn

Main Article Content

Abstract

Objective: Analysis the current situation of vancomycin use at Nghe An Friendship General Hospital at 2022. Subjects and methods: A retrospective descriptive study on 304 medical records using Vancomycin at Nghe An General Hospital in the period from January 1, 2022 to December 31, 2022. Results: The average age of the patients was 59 years old, of which men accounted for 65.78%. Discharge results: 74.01% of patients recovered/recovered; 25.99% of patients were seriously ill/returned/died. Vancomycin is mainly indicated empiric (90% indicated for empiric and 10% indicated for bacterial target. 92.11% of patients were assigned to microbiological culture in which 87.5% of patients had positive results. aureus is the most commonly isolated Gram (+)  agent. Up to 72.38% of patients received a loading dose. The maintenance dose regimen for non-dialysis patients used mainly in hospital is 1g/12h and 1g/24h corresponding to glomerular filtration rate ClCr > 50ml/min and 10-50ml/min Conclusion: The rate of isolated MRSA was 84.37% among isolated staphylococci strains. still maintain the sensitivity level of 100% on strains of S. aureus and Enterococcus.Patients were assigned loading dose of vancomycin with the rate: 72.38%.

Article Details

References

1. Álvarez R., López Cortés L.E., Molina J., et al. (2016). Optimizing the Clinical Use of Vancomycin. Antimicrob Agents Chemother, 60 (5), 2601–2609.
2. Rybak M., Lomaestro B., Rotschafer J.C., et al. (2009). Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm, 66(1), 82–98.
3. Anh N.T.M. (2019). Phân tích thực trạng sử dụng kháng sinh Vancomycin tại Bệnh viện Thanh Nhàn. Luận Van Thạc Sĩ Dược học.
4. Vu T.V.D., Choisy M., Do T.T.N., et al. (2021). Antimicrobial susceptibility testing results from 13 hospitals in Viet Nam: VINARES 2016-2017. Antimicrob Resist Infect Control, 10(1), 78.
5. Roberts J.A. and Lipman J. (2009). Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med, 37(3), 840–851; quiz 859.
6. Mai M.T., Hà N.T., Chính Đ.Đ., et al. (2021). Thực trạng sử dụng vancomycin tại Bệnh viện Trung ương Quân đội 108. J 108 - Clin Med Phamarcy.
7. Rybak M.J., Le J., Lodise T.P., et al. (2020). Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm, 77(11), 835–864.